Laurel Wealth Advisors (North Carolina)’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-6
Closed -$1K 544
2022
Q2
$1K Hold
6
﹤0.01% 574
2022
Q1
$2K Hold
6
﹤0.01% 572
2021
Q4
$2K Hold
6
﹤0.01% 573
2021
Q3
$3K Hold
6
﹤0.01% 534
2021
Q2
$3K Hold
6
﹤0.01% 599
2021
Q1
$4K Buy
+6
New +$4K ﹤0.01% 519